Fentanilo Matrix Cinfa

Fentanilo Matrix Cinfa is a transdermal patch designed for pain management. This medication contains fentanyl, a potent opioid analgesic, and is manufactured by Laboratorios Cinfa S.A. in the EU.

Fentanilo Matrix Cinfa is primarily used for the management of chronic pain that requires around-the-clock, long-term opioid treatment. It is often prescribed for individuals who have developed a tolerance to other pain medications. The transdermal patch delivers fentanyl through the skin, providing sustained pain relief over an extended period. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of Fentanilo Matrix Cinfa may include drowsiness, dizziness, nausea, and constipation. Some users may also experience itching or redness at the application site. These effects can vary from person to person and may subside as the body adjusts to the medication. Always follow the advice of a healthcare professional regarding the use of this transdermal patch.

Fentanilo Matrix Cinfa should be handled with care to avoid accidental exposure. The patch should be applied to a clean, dry area of the skin and should not be cut or altered. It is important to keep the medication out of reach of children and pets. Patients should also be aware of the potential for respiratory depression, especially when starting the treatment or increasing the dose.

Fentanilo Matrix Cinfa may interact with other medications, including other opioids, benzodiazepines, and certain antidepressants. Alcohol consumption should be avoided while using this medication, as it can enhance the sedative effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.